Massive french study tracks Real-World health of half a million diabetes patients
NCT ID NCT05882071
Summary
This study aims to understand how SGLT2i diabetes drugs are prescribed and used in France by analyzing health records. It will track over 500,000 patients starting this treatment to see if it is linked to real-world health outcomes like heart attacks, strokes, heart failure, and kidney disease. The goal is to gather knowledge about the drug's use and potential effects, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boehringer Ingelheim
Paris, 75013, France
Conditions
Explore the condition pages connected to this study.